Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer Patients
Wen-Zhuo He et al.
JOURNAL OF CANCER (2017)
The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial
Chang Woo Kim et al.
TRIALS (2016)
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
Julian Holch et al.
VISCERAL MEDICINE (2016)
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
S. Y. Brule et al.
EUROPEAN JOURNAL OF CANCER (2015)
Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis
Yuji Miyamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Influence of Body Mass Index (BMI) on Colorectal Cancer Mutation Status
S. C. Kamran et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Fotios Loupakis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Fotios Loupakis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Does the Primary Site of Colorectal Cancer Impact Outcomes for Patients With Metastatic Disease?
Timothy J. Price et al.
CANCER (2015)
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
E. Missiaglia et al.
ANNALS OF ONCOLOGY (2014)
Association Between Palliative Resection of the Primary Tumor and Overall Survival in a Population-Based Cohort of Metastatic Colorectal Cancer Patients
Gillian Gresham et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer - a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)
Jorine't Lam-Boer et al.
BMC CANCER (2014)
Survival Impact of Surgical Resection of Primary Tumor in Patients With Stage IV Colorectal Cancer
Shahid Ahmed et al.
CANCER (2014)
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
M. K. Boisen et al.
ANNALS OF ONCOLOGY (2013)
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS - a randomised controlled multicentre trial (ISRCTN30964555)
Nuh N. Rahbari et al.
BMC CANCER (2012)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
Toshiaki Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Impact of BRAF Mutation and Microsatellite Instability on the Pattern of Metastatic Spread and Prognosis in Metastatic Colorectal Cancer
Ben Tran et al.
CANCER (2011)
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Gordon Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
Frank A. Sinicrope et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Implementing prognostic and predictive biomarkers in CRC clinical trials
Sandra Van Schaeybroeck et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
Dora Dias-Santagata et al.
PLOS ONE (2011)
Predictive and Prognostic Markers in Colorectal Cancer
Ben George et al.
CURRENT ONCOLOGY REPORTS (2011)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata et al.
EMBO MOLECULAR MEDICINE (2010)
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
J. Souglakos et al.
BRITISH JOURNAL OF CANCER (2009)
Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment
George A. Poultsides et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
How aggressive should we be in patients with stage IV colorectal cancer?
LJ Kuo et al.
DISEASES OF THE COLON & RECTUM (2003)
Are there two sides to colorectal cancer?
B Iacopetta
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
